Secondary Logo

Journal Logo

Articles by Antonella Castagna

Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression

Dell’acqua, Raffaele; Galli, Laura; Poli, Andre; More

AIDS. ., Post Acceptance: July 10, 2019

Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy

Castagna, Antonella; Rusconi, Stefano; Gulminetti, Roberto; More

AIDS. 33(7):1256-1260, June 1, 2019.

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

Mocroft, Amanda; Laut, Kamilla; Reiss, Peter; More

AIDS. 32(2):205-215, January 14, 2018.

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

Galli, Laura; Spagnuolo, Vincenzo; Poli, Andrea; More

AIDS. 28(16):2407-2415, October 23rd, 2014.

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

Castagna, Antonella; Spagnuolo, Vincenzo; Galli, Laura; More

AIDS. 28(15):2269-2279, September 24th, 2014.

Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease

Ghezzi, Silvia; Galli, Laura; Kajaste-Rudnitski, Anna; More

AIDS. 27(15):2335-2344, September 24th, 2013.

Polyclonal serum-free light chains elevation in HIV-infected patients

Bibas, Michele; Lorenzini, Patrizia; Cozzi-Lepri, Alessandro; More

AIDS. 26(16):2107-2110, October 23rd, 2012.

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

Bigoloni, Alba; Gianotti, Nicola; Spagnuolo, Vincenzo; More

AIDS. 26(14):1837-1840, September 10th, 2012.

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

Marchetti, Giulia; Cozzi-Lepri, Alessandro; Merlini, Esther; More

AIDS. 25(11):1385-1394, July 17th, 2011.

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

Nozza, Silvia; Galli, Laura; Visco, Francesca; More

AIDS. 24(6):924-928, March 27th, 2010.

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

Canducci, Filippo; Sampaolo, Michela; Marinozzi, Maria Chiara; More

AIDS. 23(4):455-460, February 20th, 2009.

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)

Castagna, Antonella; Danise, Anna; Menzo, Stefano; More

AIDS. 20(6):795-803, April 4th, 2006.

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

Cinque, Paola; Vago, Luca; Dahl, Helena; More

AIDS. 10(9):951-958, 1996.